TESTIMONIAL
Marie Gaire is a Student at the School of Biology-Biochemistry-Biotechnology (ESTBB), Lyon, France. The LPCE laboratory was pleased to host her for an intership between the 29th of April and the 13th of September 2024. Here is her testimony: “I was lucky enough to be able to carry out a 5-month end-of-studies internship in the […]
TESTIMONIAL
Mathieu Garcia is a Student in Pharmaceutical Sciences, Research field Montpellier, France. The LPCE laboratory was pleased to host him for an intership between the 8th of April and the 31th of July 2024. Here is his testimony: “During my four-month internship at the Laboratory of Clinical and Experimental Pathology (LPCE), I had the opportunity […]
TESTIMONIAL
Rebecca Rossetti is a PhD biologist at the University ” G. D’ Annunzio ” Chieti- Pescara. The LPCE laboratory was pleased to host her for an intership between June and September 2024. Here her testimony: “It was for me an unique, valuable and unforgettable experience that enriched me personally and professionally. Initially I was worried […]
TESTIMONIAL
Feedback of Rhea, a Lebanese student experience in LPCE laboratory and Biobank.
TESTIMONIAL
Feedback of Elena, a Romanian student experience in LPCE laboratory and Biobank.
Training program “Master Class” in collaboration with AstraZeneca on liquid biopsy in lung cancer.
The Clinical and Molecular Pathology Laboratory at Nice University Hospital (Pr P. Hofman) is a leading center in the field of liquid biopsy using both Amplicon and Hybrid-Capture NGS strategies. A training program called “liquid biopsy expertise center” has been set up in collaboration with the AstraZeneca laboratory. Liquid biopsy, which is less invasive than tissue biopsy and takes less time to analyze, is recommended internationally.
TESTIMONIAL
Feedback of Jonathan, an Australian pathologist experience in LPCE laboratory and Biobank.
TESTIMONIAL
Feedback of Florian, a German Erasmus student experience in LPCE laboratory and Biobank
Lung cancer: progress on all fronts.
Gathered in Nice under the leadership of Prof. HOFMAN, the world’s leading specialists in this disease present a hopeful assessment of the current situation.
